Who invested in Ascribe Bioscience?
Ascribe Bioscience's investors include National Science Foundation, Creative Destruction Lab, Cultivation Capital and The Yield Lab.
United States · Series A startup
One round we have observed, with the 4 investors named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$12Mraised across 1 round since 2025, from 1 source
Source recordedSEC filing: $15M sold, first sale Oct 2025
Ascribe Bioscience's investors include National Science Foundation, Creative Destruction Lab, Cultivation Capital and The Yield Lab.
Ascribe Bioscience has raised $12M across 1 round since 2025.
Ascribe Bioscience's most recent round was a Series A of $12M in Oct 2025.
Its most recent round, $12M in Oct 2025, is also its largest on record.
Ascribe Bioscience's first round on record, in Oct 2025, was backed by National Science Foundation, Creative Destruction Lab and Cultivation Capital and 1 others.
Ascribe Bioscience's latest named round is a Series A, in Oct 2025.
Ascribe Bioscience is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.